摘要 : The treatment of newly diagnosed multiple myeloma has changed dramatically over the past 20 years, from near uniform application of chemotherapy to a patient performance status- and risk-based approach. Furthermore, initiation of ... 展开
作者 | Ella Willenbacher Agnes Balog Wolfgang Willenbacher |
---|---|
作者单位 | |
期刊名称 | 《Memo - Magazine of European medical oncology》 |
总页数 | 6 |
语种/中图分类号 | 英语 / R73 |
关键词 | Multiple myeloma Multiple myeloma treatment indication Multiple myeloma 1st line therapy Multiple myeloma transplant eligible Multiple myeloam transplant ineligible |
馆藏号 | N2010EPST0000934 |